Autopsy report · NCT04035174

Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa

“Study site was changed to another countr”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Center for Research on Filariasis and Other Tropical Diseases, Cameroon

Sponsor type

University, hospital or other

Conditions

Onchocerciasis; Loiasis; Diagnoses Disease; Neglected Diseases

Interventions

LTS-2 DEC patch; Skin snips

Participants

0

Sites

1

Countries

Cameroon

Trials that died the same way

• A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
  “Study design was changed” (67% match in meaning)
• Thoracic Kyphosis and Osteoporosis: Study of Their Relationship With Respiratory Functions in Chronic Obstructive Pulmonary Disease.
  “The site is no more able to conduct the study” (64% match in meaning)
• Cerebral NIRS Monitoring During Anesthesia in Neonates and Infants
  “Study investigators changed institution” (63% match in meaning)
• Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia
  “Personnel changes at study site.” (62% match in meaning)
• Post-operative Satisfaction With Glaucoma Surgery Trial
  “study sites were reconsidered.” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.